These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37854058)

  • 1. The genetics of urinary microbiome, an exploration of the trigger in calcium oxalate stone.
    Yang Y; Miao L; Lu Y; Wang S
    Front Genet; 2023; 14():1260278. PubMed ID: 37854058
    [No Abstract]   [Full Text] [Related]  

  • 2. Enterobacter cloacae: a villain in CaOx stone disease?
    Yang Y; Hong S; Xu J; Li C; Wang S; Xun Y
    Urolithiasis; 2022 Apr; 50(2):177-188. PubMed ID: 35124708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal pelvis urobiome in the unilateral kidney stone patients revealed by 2bRAD-M.
    Hong SY; Yang YY; Xu JZ; Xia QD; Wang SG; Xun Y
    J Transl Med; 2022 Sep; 20(1):431. PubMed ID: 36153619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6.
    Liu Y; Jin X; Ma Y; Jian Z; Wei Z; Xiang L; Sun Q; Qi S; Wang K; Li H
    mSystems; 2021 Dec; 6(6):e0104521. PubMed ID: 34783577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome of calcium-based urinary stones.
    Dornbier RA; Bajic P; Van Kuiken M; Jardaneh A; Lin H; Gao X; Knudsen B; Dong Q; Wolfe AJ; Schwaderer AL
    Urolithiasis; 2020 Jun; 48(3):191-199. PubMed ID: 31240349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The urinary microbiota composition and functionality of calcium oxalate stone formers.
    Xie J; Zhang XQ; Guo JN; Yuan Q; Xiao KF; Yuan YQ
    Front Cell Infect Microbiol; 2024; 14():1394955. PubMed ID: 38912208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
    Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
    J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats.
    Wang Y; Sun J; Xie S; Zhou Y; Wang T; Liu Z; Li C; Gao L; Pan T
    Front Cell Infect Microbiol; 2023; 13():1145196. PubMed ID: 37313343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
    More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
    Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the stone composition of children preoperatively by Hounsfield unit detection on non-contrast computed tomography.
    Altan M; Çitamak B; Bozaci AC; Güneş A; Doğan HS; Haliloğlu M; Tekgül S
    J Pediatr Urol; 2017 Oct; 13(5):505.e1-505.e6. PubMed ID: 28427913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between bacteria and urinary stones.
    Schwaderer AL; Wolfe AJ
    Ann Transl Med; 2017 Jan; 5(2):32. PubMed ID: 28217697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinegar reduced renal calcium oxalate stones by regulating acetate metabolism in gut microbiota and crystal adhesion in rats.
    Liu Y; Jin X; Ma Y; Sun Q; Li H; Wang K
    Int Urol Nephrol; 2022 Oct; 54(10):2485-2495. PubMed ID: 35852714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Copper and Zinc Ions on Biochemical and Molecular Characteristics of Calcium Oxalate Renal Stones: a Controlled Clinical Study.
    Taha SAY; Shokeir AA; Mortada WI; Awadalla A; Barakat LAA
    Biol Trace Elem Res; 2024 Feb; 202(2):410-422. PubMed ID: 37191760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Dietary and Medical Prevention of Renal Calcium Oxalate Stones.
    Wang X; Wang Q
    Int J Gen Med; 2024; 17():1635-1649. PubMed ID: 38706742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.